Percutaneous radiofrequency ablation of hepatocellular lesions in segment II of the liver: A risk factor for cardiac tamponade

Eric R. Silverman, Yan H. Lai, Irene P. Osborn, Francine S. Yudkowitz

Research output: Contribution to journalArticle

4 Scopus citations


Percutaneous radiofrequency ablation (PRFA) is a minimally invasive procedure used for the treatment of small hepatocellular carcinomas. PRFA is regarded as a much safer alternative to surgical resection or orthotopic liver transplantation. However, serious complications, including cardiac tamponade, have been reported. Two cases of severe cardiac tamponade during PRFA were successfully treated.

Original languageEnglish (US)
Pages (from-to)587-590
Number of pages4
JournalJournal of Clinical Anesthesia
Issue number7
Publication statusPublished - Nov 1 2013
Externally publishedYes



  • Cardiac tamponade
  • Hepatocellular carcinoma
  • Liver carcinoma
  • Percutaneous radiofrequency ablation
  • Thermoablation

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this